Keyphrases
Nursing Homes
50%
Dementia
45%
Meta-epidemiological Study
38%
Mortality Risk
33%
Delirium
29%
Evolocumab
28%
Elderly Outpatients
24%
Test Accuracy Studies
24%
Baseline Imbalance
24%
Placebo
22%
Confidence Interval
22%
Neuropsychiatric Symptoms
21%
Atypical Antipsychotics
20%
PCSK9 Inhibitors
18%
Conventional Antipsychotics
18%
Clinical Outcomes
18%
Extrapyramidal Symptoms
17%
Caregivers
17%
Randomized Trial
16%
Meta-analysis
16%
Older Outpatients
15%
Cognitive Impairment
15%
Dutch
14%
Randomized Placebo-controlled Trial
14%
Alirocumab
14%
Nursing Home Residents
14%
Serious Adverse Events
14%
Alzheimer's Disease
12%
Drug Treatment
12%
Polypharmacy
12%
Matched Case-control Study
12%
Co-medication
12%
Depressive Symptoms
12%
Objective Outcome
12%
Systematic Meta-analysis
12%
Ambience
12%
Elderly Patients
12%
Health Impact
12%
Antipsychotics
12%
Vascular Brain Disease
12%
Agitation
12%
Depression in Elderly
12%
Long-term Mortality
12%
Triage
12%
Fourier
12%
Electronic Health Record Data
12%
National Cohort Study
12%
Long-term Care Residents
12%
Nursing Home Care
12%
All-cause Mortality
11%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Typical Antipsychotic
86%
Symptom
58%
Atypical Antipsychotics
42%
Delirium
41%
Adverse Event
40%
Evolocumab
32%
Extrapyramidal Symptoms
24%
Alzheimer's Disease
24%
All Cause Mortality
17%
Cognitive Defect
17%
Heart Infarction
17%
Prevalence
16%
Alirocumab
16%
Diabetes Mellitus
16%
Observational Study
14%
Somnolence
13%
Case-Control Study
13%
Cardiovascular Disease
13%
Pharmacotherapy
12%
Polypharmacy
12%
Multiinfarct Dementia
12%
Terminal Disease
12%
Low Density Lipoprotein Cholesterol
12%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
11%
Antipsychotic
10%
Cause of Death
6%
Side Effect
6%
Psychosis
6%
Ezetimibe
6%
Nursing and Health Professions
Delirium
90%
Nursing Home
90%
Systematic Review
49%
Outpatient
49%
Cognitive Defect
25%
Typical Antipsychotic
25%
Practice Guideline
24%
Long Term Care
17%
Prevalence
14%
Elderly Patient
14%
Symptom
13%
Terminal Disease
12%
Nursing Staff
12%
Meta Analysis
12%
Placebo
12%
Triage
12%
Sensitivity and Specificity
12%
Attention Test
12%
Physical Disease by Body Function
12%
Nursing Home Care
12%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
10%
Confidence Interval
9%
Sound Intensity
8%
Medline
7%
Attributable Risk
7%
Disease
6%
Sedation
5%
